Member Info for 86KB

For those who are saying no patent filed

Following its announcement of 24 October 2024 regarding Method C AI Oracle, QBT, the AIM-listed investment company focused on an R&D and investment programme within blockchain technology, is pleased to confirm the filing of a new patent application covering Method C’s disruptive AI Oracle (“AI Oracle”): “IMPLEMENTATION OF BINARY DECISION TREES”.

The were in discussion with North American miners so could expect some agreements from this soon

Patent probably already filed last year as mentioned, they don't need to update the marker about it.

If you havn't followed this company then knows its been a long time for them to get here. Absolutely brilliant news especially when btc is heading higher each day

Imagine a deal with roche..

Every year, Roche sets aside around $10 billion for potential M&A deals, but CEO Teresa Graham revealed at JPM25 that the pharma is selective in how and whether it spends this money, Fierce Biotech reported on Tuesday.

This fiscal control was in full display last year, Richard Vosser, analyst at J.P. Morgan, pointed out during the Q&A session of Roche’s presentation, according to Fierce. Some of the pharma’s recent deals include its $900 million partnership with COUR Pharmaceuticals last month and potential $1.8 billion contract with Flare Therapeutics in November 2024. Most prominent is Roche’s $1.5 billion acquisition of Poseida Therapeutics, also in November.

Still, Graham maintained that the pharma has the capacity—and willingness—to make big-ticket acquisitions “if and when we find transformative assets that are either complementary to our portfolio” or “change the game in important diseases.”

Just a reminder they will be having discussions with global pharma companies that have shown interest. Final day to and hopefully get update tomorrow.

Attending and taking meetings at both the JP Morgan conference and the Biotech Showcase offers the opportunity to continue discussions across our whole unique portfolio and specifically with global BioPharma companies that have an interest in autoimmune diseases demonstrated within our P140 technology platform.

Think we should see that gap fill at 2.74 soon

Whats bonkers is there has been so many cross ramping on this board. I am sure everyone can see the risers list and news to see if they want in on any of them.

No golden cross yet but heading for that way. But we shall see what happens end of play.

Well done to those who got the lows absolute bargain. Back above 3p

Spread is tighter than advertised

Try this one as price has gone up https://invst.ly/18giii

Https://invst.ly/18gigu

At msuk try this

Looking better here, should get some news. Tomorrow the last day get retail placing shares right?

Msuk if you use sars look how its bounced off that, the other MA will just catch up. Plus if you just rely on charts you must have noticed there is golden cross coming soon which you know what it means especially when we know news is due here.

The spread is false they are taking it up

Think bottom is in, fallen from 5.4 to lows of 2.2 anybody would think there was no news. But to have a deal with J&J and mcap being back below 4mcap is ridiculous. Today is the last day of event we could get some kind of update.

Today is the last day of the event I am sure we will get an update on how the event went.

Msuk charts cant predict news yes use charts as a guideline but when news lands it will do its thing. But you need to go off fundamentals too. The fundamentals here are great. We are on the cusp of getting licensing deals which could be worth billions.